Allograft and patient outcomes between Indigenous and non-Indigenous kidney transplant recipients

Transplantation
Prue HowsonWai H Lim

Abstract

Kidney transplant outcomes of Indigenous Australians are poorer compared to non-Indigenous Australians, but it is unknown whether the type of acute rejection differs between these patient groups, or whether rejection mediates the effect between ethnicity, death-censored graft failure (DCGF) and death with a functioning graft (DWFG). Biopsy-proven acute rejection (BPAR) rates and types were compared between Indigenous and non-Indigenous recipients. The associations between ethnicity, BPAR, DCGF and DWFG were examined using adjusted competing risk analyses; and mediation analysis was conducted to determine whether BPAR mediated the adverse effects between ethnicity and outcomes. Fifty-seven (9.3%) of 616 patients who have received kidney-only transplants between 2000-2010 in Western Australia were Indigenous. Compared to non-Indigenous recipients, BPAR rates were higher in Indigenous recipients (42 vs. 74 episodes/100 recipients, p<0.01), with an excess of antibody-mediated rejections. During a median follow-up of 8-years, Indigenous recipients were more likely to experience BPAR, DCGF and DWFG compared to non-Indigenous recipients, with adjusted subdistribution hazard ratio (HR) of 1.94 (1.39, 2.70), 1.53 (0.85, 2.76; p=0.159), ...Continue Reading

References

Aug 1, 1997·Tissue Antigens·X GaoJ McCluskey
Jan 28, 2003·Transplantation·Yvo W J SijpkensLeendert C Paul
Oct 11, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nicolas PalletChristophe Legendre
Jun 15, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C L C WeberM E Karpinski
Mar 16, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S McDonaldS Chadban
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Alexander S Goldfarb-RumyantzevRoss B Isaacs
Mar 14, 2008·Transplantation·Gerhard OpelzUNKNOWN Collaborative Transplant Study Report
Oct 31, 2008·Journal of the American Society of Nephrology : JASN·Karen YeatesMarcello Tonelli
Jul 17, 2010·Journal of the American Society of Nephrology : JASN·Carmen LefaucheurCaroline Suberbielle-Boissel
Oct 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·I W Gibson
Oct 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·I BatalP Randhawa
Mar 21, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C WiebeP W Nickerson
Dec 5, 2015·Transplantation·Katherine A BarracloughStephen P McDonald
Feb 6, 2016·Journal of the American Society of Nephrology : JASN·Tanjala S PurnellDorry L Segev
Aug 25, 2016·Kidney International·David J TaberLeonard E Egede
Apr 4, 2017·Internal Medicine Journal·Peter BoanAshley Irish

❮ Previous
Next ❯

Citations

Oct 9, 2019·The Medical Journal of Australia·Wai H LimGermaine Wong

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

STATA

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.